Home / Share Price Target / Astrazen
AstraZeneca Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
AstraZeneca Pharma India Limited | |||
 | Symbol: ASTRAZEN | ||
| Price: ₹6,772.95 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: AstraZeneca Pharma Brief Company Overview
- 1.1: AstraZeneca Pharma India Limited: A Leading Biopharmaceutical Company
- 1.2: AstraZeneca Pharma Financial Performance
- 1.2.1: Is AstraZeneca Pharma A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: AstraZeneca Pharma Share Price Target For 2024
- 2.1.1: AstraZeneca Pharma Share Price Target Table For 2024
- 2.1.2: Summary: AstraZeneca Pharma Share Price Prediction For 2024
- 2.2: AstraZeneca Pharma Share Price Target For 2025
- 2.2.1: AstraZeneca Pharma Share Price Target Table For 2025
- 2.2.2: Summary: AstraZeneca Pharma Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: AstraZeneca Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: AstraZeneca Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: AstraZeneca Pharma Past Performance
AstraZeneca Pharma Brief Company Overview
AstraZeneca Pharma India Limited: A Leading Biopharmaceutical Company
AstraZeneca Pharma India Limited, established in 1979, is a renowned biopharmaceutical company with operations across India and globally. As a leading manufacturer and marketer of pharmaceuticals, AstraZeneca Pharma India caters to the diverse healthcare needs of patients.
The company boasts a comprehensive product range, including innovative treatments for cardiovascular diseases, diabetes, respiratory conditions, oncology, renal diseases, and metabolic disorders. Their notable brands include Brilinta, Betaloc, Crestor, and Symbicort, among others.
AstraZeneca Pharma India's commitment to research and innovation has earned it a remarkable reputation in the industry. Their diverse product portfolio ensures they cater to a broad spectrum of healthcare needs, making them a trusted partner for patients, healthcare providers, and the industry at large.
- Key Products: Cardiovascular drugs, diabetes treatments, respiratory medicines, oncology therapeutics, renal products, metabolic treatments, immunology therapies
- History: Founded in 1979, headquartered in Bengaluru, India
- Market Presence: Operates in India and internationally
- Reputation: Recognized for innovation, quality, and commitment to patient care
- Diverse Product Range: Addresses a wide range of healthcare needs
- Commitment: To provide innovative therapies for improving patient outcomes
Advertisement
AstraZeneca Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 18,792.5 Crore | Market valuation of AstraZeneca Pharma's shares. |
| Revenue (TTM) | 1,387.58 Crore | Total revenue generated by AstraZeneca Pharma over the past twelve months. |
| Net Income (TTM) | +95.86 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 8.81% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 6.9% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +31.2% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 0.64 | Company's total debt divided by total shareholder equity. |
| Total Debt | 4.59 Crore | Sum of AstraZeneca Pharma's current & long-term financial obligations. |
| Total Cash | 505.56 Crore | Total amount of liquid funds available to AstraZeneca Pharma. |
| Beta | 0.28 | Beta is less than 1 indicating that the AstraZeneca Pharma's price is less volatile than the market. |
Is AstraZeneca Pharma A Good Buy For Long Term?
AstraZeneca Pharma, a mid-cap stock with a market capitalization of ₹16,942.94 crore, shows strong growth potential. While Q1 2024-25 revenue increased by 31.2% and the profit margin sits at 6.9%, a relatively low debt of ₹4.59 crore against a cash balance of ₹505.56 crore is encouraging. Past performance is impressive, with 12-month returns at 44.89% and 5-year returns at a remarkable 366.47%. Although recent 3-month returns dipped slightly (-3.75%), its long-term prospects appear positive, making it a good buy for long-term investors.
To predict the AstraZeneca Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
AstraZeneca Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of AstraZeneca Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for AstraZeneca Pharma shares in 2024, see the table below.
Advertisement
AstraZeneca Pharma Share Price Target Table For 2024
| AstraZeneca Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 7025.00 (+3.72%) | Price Action: 25 Oct 2024 Low |
| 2024 Target 2 | 6955.00 (+2.68%) | Price Action: 29 Oct 2024 Low |
| 2024 Target 1 | 6872.00 (+1.46%) | Price Action: Jan 2024 High |
| Current Price | 6772.95 | AstraZeneca Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 6718.79 (-0.8%) | Price Action: Aug 2024 High |
| Stop Loss 2 | 6596.97 (-2.6%) | Technical Indicator: MA150 |
| Stop Loss 3 | 6500.19 (-4.03%) | Fibonacci Retracement Extended 40% |
Summary: AstraZeneca Pharma Share Price Prediction For 2024
In summary, AstraZeneca Pharma has surged by ₹1246.35, achieving a notable +22.55% increase from 1st January 2024 to 14 Nov 2024. Our analysis of AstraZeneca Pharma for 2024 predicts an additional rise of 1.46% to 3.72% by the end of 2024 with three potential targets T1: 6872.00, T2: 6955.00, T3: 7025.00. Stop Loss at SL1: 6718.79, SL2: 6596.97, SL3: 6500.19.
AstraZeneca Pharma has a 52-week high of ₹8139.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹4510.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for AstraZeneca Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
AstraZeneca Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of AstraZeneca Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for AstraZeneca Pharma shares in 2025, see the table below.
Advertisement
AstraZeneca Pharma Share Price Target Table For 2025
| AstraZeneca Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 9300.62 (+37.32%) | Price Action: Chart |
| 2025 Target 2 | 9127.20 (+34.75%) | Custom Fibonacci Extension Lvl 64.9% |
| 2025 Target 1 | 8993.59 (+32.78%) | Fibonacci Extension Level 123.6% |
| Current Price | 6772.95 | AstraZeneca Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 6206.25 (-8.37%) | Price Action: Jun 2024 Low |
| Stop Loss 2 | 6140.00 (-9.35%) | Price Action: May 2024 Low |
| Stop Loss 3 | 6029.48 (-10.98%) | Price Action: Chart |
Summary: AstraZeneca Pharma Share Price Prediction For 2025
In summary, AstraZeneca Pharma has surged by ₹1246.35, achieving a notable +22.55% increase from 1st January 2024 to 14 Nov 2024. Our analysis of AstraZeneca Pharma for 2025 predicts an additional rise of 32.78% to 37.32% by the end of 2025 with three potential targets T1: 8993.59, T2: 9127.20, T3: 9300.62. Stop Loss at SL1: 6206.25, SL2: 6140.00, SL3: 6029.48.
AstraZeneca Pharma has a All-Time high of ₹8139.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹4510.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for AstraZeneca Pharma, we have created a specific page for that check here: AstraZeneca Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
AstraZeneca Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of AstraZeneca Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 11.73% over the next 15 years.
For complete year by year AstraZeneca Pharma long term share price target from 2024, 2025 to 2039 check the below table.
AstraZeneca Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | AstraZeneca Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹6,772.95 | [Current Price] |
| 2024 | ₹8,292.78 | 22.43% |
| 2025 | ₹9,956.68 | 20.06% |
| 2026 | ₹11,229.68 | 12.78% |
| 2027 | ₹14,335.13 | 27.65% |
| 2028 | ₹17,010.62 | 18.66% |
| 2029 | ₹19,209.22 | 12.92% |
| 2030 | ₹20,331.91 | 5.84% |
| 2031 | ₹20,913.27 | 2.85% |
| 2032 | ₹24,878.3 | 18.95% |
| 2033 | ₹27,917.24 | 12.21% |
| 2034 | ₹30,125.66 | 7.91% |
| 2035 | ₹30,707.13 | 1.93% |
| 2036 | ₹30,596.87 | -0.36% |
| 2037 | ₹35,421.48 | 15.76% |
| 2038 | ₹38,823.86 | 9.6% |
| 2039 | ₹39,187.25 | 0.93% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
AstraZeneca Pharma Past Performance
- In 1992, AstraZeneca Pharma opening price was ₹17.5
- As of Thu 14 Nov 2024 the price stands at ₹6,772.95.
- This represents a Compound Annual Growth Rate (CAGR) of 19.79%.
- In 32 years, an investment of 10,000 would have become ₹38.7 Lakh.
As we wrap up, we hope you like our study on AstraZeneca Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- AstraZeneca Pharma Share Price History
- AstraZeneca Pharma Price Target Tomorrow
- AstraZeneca Pharma Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
